Most recent studies regarding the role of inflammation in the pathogenesis of AD and control of immune response indicated that an alteration (mutation) in the triggering receptor expressed on myeloid cells 2 (TREM2) has a greater possibility of causing AD [72,73,74]. The gene discussed is TREM2; the disease is Alzheimer disease.